The Effect of Renal Dysfunction on BNP, NT-proBNP, and Their Ratio

Abstract

We examined the effect of renal dysfunction on B-natriuretic peptide (BNP), N-terminal (NT)-proBNP, and their molar ratio at varying severities of cardiac function in 94 Thai patients with chest pain (52 men; 32 women), also measuring creatinine and left ventricular ejection fraction (LVEF). Renal function was classified into 5 stages by estimated glomerular filtration rate. The molar NT-proBNP/BNP ratio was calculated. Cardiac status was classified by LVEF (normal, >50%; moderate, 35%-50%; severe, <35%). BNP, NT-proBNP, and their ratio corresponded to renal disease stage exponential (0.51, 1.05, and 0.54, respectively; correlation coefficients, >or=0.95). BNP and the ratio are affected less than NT-proBNP by renal dysfunction, starting in stage III; NT-proBNP expresses effects starting in stage II. NT-proBNP is more sensitive than BNP to renal disease stage. For log of geometric means vs stage of renal disease, the BNP slopes and correlation coefficients vary considerably (slopes, 0.036-0.531; r(2), 0.017-0.99). The NT-proBNP slopes and regression coefficients vary considerably (slopes, 0.18-0.71; r(2), 0.33-0.99). For the ratio, the slopes show low variation (0.148-0.337), r(2) greater than 0.96, women differing from men (P = .012). The effect of renal disease differs by gender. BNP and NT-proBNP increase by stage III for women but not for men. One must consider renal function, gender, and LVEF when using BNP or NT-proBNP as cardiac biomarkers. The ratio of the 2 peptides is the most consistent marker across LVEFs.

The prevalence of renal dysfunction and its influence on the prognosis of patients with acute heart failure

“…По данным разных авторов почеч-ная дисфункция встречается у 20-57 % пациентов с ХСН, достигая 30-67 % у пациентов с ОСН. В мета-анализе K. Damman [20].…”

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE

“…In this study, the SCr patient in pre and post therapy were in the normal range (0.6-1.3 mg/dl) and there is no significant difrences between SCr levels. Decrease of renal function < 40 ml/ minute could increase NT-proBNP levels because of decreased clearance (Srisawasdi et al 2010, Tsutamoto 2006). So we calculate each patient GFR, and the result patient in this study did not had severe renal failure that could affect NT-proBNP levels.…”

In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio

“…Renal function (17,18,26,27), obesity (28)(29)(30) and inflammation (19,21) are non-cardiac factors that should be considered during BNP and NT-proBNP evaluations.…”